Secondary Logo

Institutional members access full text with Ovid®

1504

IMMUNE CHECKPOINT INHIBITORS IN SEPSIS

A PHASE 1B TRIAL OF ANTI-PD-L1 (BMS-936559)

Hotchkiss, Richard; Colston, Elizabeth; Yende, Sachin; Angus, Derek; Moldawer, Lyle; Crouser, Elliott; Martin, Greg; Coopersmith, Craig; Brakenridge, Scott; Mayr, Florian; Park, Pauline; Zhu, Kurt; Wind-Rotolo, Megan; Duan, Tao; Ye, June; Luo, Yi; Catlett, Ian; Rana, Khurram; Grasela, Dennis

doi: 10.1097/01.ccm.0000529506.43290.de
Research Snapshot Theater: Sepsis
Buy

1Washington University School of Medicine, Saint Louis, MO, 2Bristol-Myers Squibb, Inc., Lawrenceville, NJ, & Wallingford, CT, 3Veterans Affairs Pittsburgh Healthcare System & University of Pittsburgh, Pittsburgh, PA, 4University of Pittsburgh Critical Care Medicine CRISMA Laboratory, Pittsburgh, PA, 5University of Florida, Gainesville, FL, 6The Ohio State University, Columbus, OH, 7Dept. of Medicine, Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University, Atlanta, GA, 8Dept. of Surgery, Emory University, Atlanta, GA, 9University of Michigan, Ann Arbor, MI

Copyright © by 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.